Search Results 431-440 of 14760 for anti-TNF drugs

1. Emerging treatments for multiple sclerosis - Mayo Clinic

   This medicine is a self-injection treatment used for relapsing-remitting and secondary-progressive forms of MS. Ofatumumab is a medicine that destroys certain ...

2. Tacrine (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Tacrine is used to treat the symptoms of mild to moderate ...

3. Diphtheria And Tetanus Vaccine (Intramuscular Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   ... [anti-TNF] agents) within 14 days prior to randomization. Exceptions ... agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g. ...

5. Mayo Clinic Minute: Weight-loss medications alone are not a quick fix

   One of the most common New Year's resolutions is to lose weight. Many may be wondering if weight-loss medications can help them reach their goal.

6. Barbiturate (Oral Route, Parenteral Route, Rectal Route) Before Using - Mayo Clinic

   Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

7. Fighting Parkinson’s Disease and Lewy Body Dementia with Anti-Diabetic Medications to - Mayo Clinic

   Clinical Trials · Fighting Parkinson's Disease and Lewy Body Dementia with Anti-Diabetic Medications to · More about research at Mayo Clinic · Mayo Clinic Footer.

8. Tirzepatide (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Mounjaro; Zepbound. Descriptions. Tirzepatide injection is ...

9. Modified immunosuppressive regimen improves survival in heart transplant patients - Mayo Clinic

   "Prior to 2006, most heart transplant patients at Mayo Clinic in Rochester, Minnesota, received induction therapy consisting of anti-thymocyte globulin (ATG), ...

10. Oatd-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis - Mayo Clinic

    Immunosuppressants or anti-TNF agents (or other antiinflammatory/anti ... Current systemic pharmacological treatment for sarcoidosis or any systemic disease, ...